Percentage and main features of patients referred to a cardiac rehabilitation program who would have an indication for a GLP1 receptor agonist based on the SELECT trial criteria
25 April 2024 (09:00 - 12:30)
Organised by: 
Abstract
About the speaker
Son Llatzer University Hospital, Palma de Mallorca (Spain)
5 More presentations in this session
Access the full session
The Event
ESC Preventive Cardiology 2024
25 April 2024
09:00 CET
